$3.65 Billion is the total value of Rock Springs Capital Management LP's 143 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 15.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $166,713,000 | +42.7% | 1,366,500 | +1.3% | 4.57% | -5.3% |
| UNH | Buy | UNITEDHEALTH GROUP INC | $119,455,000 | +59.7% | 405,000 | +35.0% | 3.28% | +5.9% |
| CNC | Buy | CENTENE CORP DEL | $83,568,000 | +87.5% | 1,315,000 | +75.3% | 2.29% | +24.4% |
| IRTC | Buy | IRHYTHM TECHNOLOGIES INC | $75,444,000 | +43.8% | 651,000 | +0.9% | 2.07% | -4.7% |
| BPMC | Buy | BLUEPRINT MEDICINES CORP | $74,882,000 | +73.7% | 960,029 | +30.3% | 2.05% | +15.3% |
| HUM | Buy | HUMANA INC | $74,060,000 | +49.7% | 191,000 | +21.3% | 2.03% | -0.7% |
| ISRG | Sell | INTUITIVE SURGICAL INC | $68,380,000 | -9.5% | 120,000 | -21.3% | 1.88% | -39.9% |
| ZLAB | Buy | ZAI LAB LTDadr | $66,792,000 | +73.0% | 813,246 | +8.4% | 1.83% | +14.8% |
| ARGX | Buy | ARGENX SEsponsored adr | $64,754,000 | +98.6% | 287,500 | +16.2% | 1.78% | +31.8% |
| AGIO | Buy | AGIOS PHARMACEUTICALS INC | $63,091,000 | +68.5% | 1,179,720 | +11.8% | 1.73% | +11.8% |
| IMMU | Buy | IMMUNOMEDICS INC | $59,457,000 | +320.1% | 1,677,679 | +59.8% | 1.63% | +178.8% |
| PODD | Buy | INSULET CORP | $56,918,000 | +17.7% | 293,000 | +0.3% | 1.56% | -22.0% |
| BAX | BAXTER INTL INC | $55,535,000 | +6.0% | 645,000 | 0.0% | 1.52% | -29.7% | |
| SRPT | SAREPTA THERAPEUTICS INC | $55,397,000 | +63.9% | 345,500 | 0.0% | 1.52% | +8.7% | |
| HCA | Buy | HCA HEALTHCARE INC | $53,334,000 | +14.2% | 549,500 | +5.7% | 1.46% | -24.3% |
| EHC | Buy | ENCOMPASS HEALTH CORP | $51,557,000 | -1.2% | 832,500 | +2.1% | 1.41% | -34.5% |
| ACAD | Buy | ACADIA PHARMACEUTICALS INC | $51,136,000 | +18.1% | 1,055,000 | +2.9% | 1.40% | -21.7% |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $51,098,000 | +23.1% | 345,000 | -9.6% | 1.40% | -18.3% |
| RARE | Sell | ULTRAGENYX PHARMACEUTICAL IN | $50,596,000 | +52.3% | 646,841 | -13.5% | 1.39% | +1.0% |
| PCRX | Buy | PACIRA BIOSCIENCES | $48,535,000 | +60.8% | 925,000 | +2.8% | 1.33% | +6.7% |
| BIIB | BIOGEN INC | $48,159,000 | -15.4% | 180,000 | 0.0% | 1.32% | -43.9% | |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $47,794,000 | +48.8% | 387,500 | +2.0% | 1.31% | -1.3% |
| NVAX | New | NOVAVAX INC | $47,559,000 | – | 570,598 | +100.0% | 1.30% | – |
| TFX | TELEFLEX INCORPORATED | $47,317,000 | +24.3% | 130,000 | 0.0% | 1.30% | -17.5% | |
| NVRO | Buy | NEVRO CORP | $46,115,000 | +33.3% | 386,000 | +11.6% | 1.26% | -11.5% |
| NVTA | Buy | INVITAE CORP | $45,772,000 | +191.2% | 1,511,127 | +31.4% | 1.26% | +93.1% |
| MRSN | Buy | MERSANA THERAPEUTICS INC | $43,955,000 | +511.5% | 1,878,428 | +52.3% | 1.21% | +306.1% |
| SGEN | Buy | SEATTLE GENETICS INC | $42,480,000 | +52.1% | 250,000 | +3.3% | 1.16% | +0.9% |
| PTLA | Buy | PORTOLA PHARMACEUTICALS INC | $41,488,000 | +232.1% | 2,306,196 | +31.6% | 1.14% | +120.5% |
| IDXX | IDEXX LABS INC | $41,270,000 | +36.3% | 125,000 | 0.0% | 1.13% | -9.6% | |
| BGNE | Buy | BEIGENE LTDsponsored adr | $40,506,000 | +53.2% | 215,000 | +0.1% | 1.11% | +1.6% |
| EW | Buy | EDWARDS LIFESCIENCES CORP | $40,222,000 | +9.9% | 582,000 | +200.0% | 1.10% | -27.1% |
| FRPT | Buy | FRESHPET INC | $39,822,000 | +56.9% | 476,000 | +19.7% | 1.09% | +4.0% |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $39,818,000 | +51.7% | 348,761 | +2.1% | 1.09% | +0.6% |
| ALGN | Buy | ALIGN TECHNOLOGY INC | $39,245,000 | +76.9% | 143,000 | +12.2% | 1.08% | +17.3% |
| BSX | BOSTON SCIENTIFIC CORP | $38,621,000 | +7.6% | 1,100,000 | 0.0% | 1.06% | -28.6% | |
| PEN | Sell | PENUMBRA INC | $37,016,000 | +2.0% | 207,000 | -8.0% | 1.02% | -32.4% |
| EXAS | EXACT SCIENCES CORP | $36,863,000 | +49.9% | 424,000 | 0.0% | 1.01% | -0.6% | |
| VRTX | VERTEX PHARMACEUTICALS INC | $36,289,000 | +22.0% | 125,000 | 0.0% | 1.00% | -19.1% | |
| CHRS | Buy | COHERUS BIOSCIENCES INC | $36,171,000 | +14.4% | 2,025,275 | +3.9% | 0.99% | -24.2% |
| APLT | Buy | APPLIED THERAPEUTICS INC | $35,845,000 | +29.7% | 991,573 | +17.2% | 0.98% | -14.0% |
| ASMB | Sell | ASSEMBLY BIOSCIENCES INC | $34,955,000 | +57.1% | 1,498,915 | -0.1% | 0.96% | +4.2% |
| ARDX | Buy | ARDELYX INC | $34,705,000 | +25.9% | 5,015,109 | +3.4% | 0.95% | -16.5% |
| GLPG | GALAPAGOS NVspon adr | $34,526,000 | +0.7% | 175,000 | 0.0% | 0.95% | -33.2% | |
| EPZM | Buy | EPIZYME INC | $33,792,000 | +11.4% | 2,104,084 | +7.6% | 0.93% | -26.1% |
| AMRN | AMARIN CORP PLCspons adr new | $32,178,000 | +73.0% | 4,650,000 | 0.0% | 0.88% | +14.8% | |
| ASND | ASCENDIS PHARMA A Ssponsored adr | $31,577,000 | +31.3% | 213,500 | 0.0% | 0.87% | -12.9% | |
| CI | Buy | CIGNA CORP NEW | $30,212,000 | +20.9% | 161,000 | +14.2% | 0.83% | -19.7% |
| AMGN | AMGEN INC | $29,718,000 | +16.3% | 126,000 | 0.0% | 0.82% | -22.8% | |
| MDGL | Buy | MADRIGAL PHARMACEUTICALS INC | $28,796,000 | +72.5% | 254,268 | +1.7% | 0.79% | +14.5% |
| ADPT | Buy | ADAPTIVE BIOTECHNOLOGIES COR | $27,819,000 | +83.7% | 575,000 | +5.5% | 0.76% | +21.9% |
| INCY | INCYTE CORP | $25,993,000 | +42.0% | 250,000 | 0.0% | 0.71% | -5.8% | |
| MIRM | Buy | MIRUM PHARMACEUTICALS INC | $25,685,000 | +47.6% | 1,319,910 | +6.2% | 0.70% | -2.1% |
| RPRX | New | ROYALTY PHARMA PLC | $24,275,000 | – | 500,000 | +100.0% | 0.67% | – |
| INSP | Buy | INSPIRE MED SYS INC | $23,060,000 | +91.3% | 265,000 | +32.5% | 0.63% | +27.1% |
| KRTX | Buy | KARUNA THERAPEUTICS INC | $22,661,000 | +74.9% | 203,312 | +13.0% | 0.62% | +16.0% |
| ACHC | ACADIA HEALTHCARE COMPANY IN | $22,608,000 | +36.9% | 900,000 | 0.0% | 0.62% | -9.2% | |
| RTRX | Buy | RETROPHIN INC | $20,905,000 | +149.2% | 1,024,261 | +78.1% | 0.57% | +65.1% |
| ALXN | New | ALEXION PHARMACEUTICALS INC | $20,596,000 | – | 183,500 | +100.0% | 0.56% | – |
| COLL | COLLEGIUM PHARMACEUTICAL INC | $20,563,000 | +7.2% | 1,175,000 | 0.0% | 0.56% | -28.9% | |
| APRE | Buy | APREA THERAPEUTICS INC | $20,099,000 | +15.6% | 518,290 | +3.7% | 0.55% | -23.4% |
| ADAP | Buy | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $19,889,000 | +509.3% | 1,986,910 | +65.6% | 0.55% | +304.4% |
| CYTOKINETICS INCnote 4.000%11/1 | $19,082,000 | +80.5% | 8,000,000 | 0.0% | 0.52% | +19.7% | ||
| ALLO | Buy | ALLOGENE THERAPEUTICS INC | $18,861,000 | +288.1% | 440,468 | +76.2% | 0.52% | +157.2% |
| HQY | Buy | HEALTHEQUITY INC | $18,780,000 | +21.7% | 320,100 | +5.0% | 0.52% | -19.3% |
| ODT | Buy | ODONATE THERAPEUTICS INC | $18,512,000 | +55.9% | 437,231 | +1.7% | 0.51% | +3.5% |
| PHR | Buy | PHREESIA INC | $18,424,000 | +55.1% | 651,500 | +15.3% | 0.50% | +2.9% |
| QURE | Buy | UNIQURE NV | $18,345,000 | -3.3% | 407,133 | +1.8% | 0.50% | -35.9% |
| GBT | Buy | GLOBAL BLOOD THERAPEUTICS IN | $18,199,000 | +27.2% | 288,279 | +3.0% | 0.50% | -15.6% |
| TBPH | Buy | THERAVANCE BIOPHARMA INC | $17,384,000 | +0.3% | 828,218 | +10.4% | 0.48% | -33.5% |
| ALLK | Buy | ALLAKOS INC | $17,177,000 | +64.3% | 239,032 | +1.7% | 0.47% | +9.0% |
| CGEN | Buy | COMPUGEN LTDord | $16,978,000 | +112.6% | 1,130,375 | +2.8% | 0.47% | +41.2% |
| MYOK | Buy | MYOKARDIA INC | $16,688,000 | +115.7% | 172,716 | +4.7% | 0.46% | +43.1% |
| FUSN | New | FUSION PHARMACEUTICALS INC | $16,370,000 | – | 937,041 | +100.0% | 0.45% | – |
| ARVN | Buy | ARVINAS INC | $16,148,000 | +40.6% | 481,468 | +68.9% | 0.44% | -6.7% |
| WST | WEST PHARMACEUTICAL SVSC INC | $16,129,000 | +49.2% | 71,000 | 0.0% | 0.44% | -1.1% | |
| New | GOSSAMER BIO INCnote 5.000% 6/0 | $15,746,000 | – | 15,573,000 | +100.0% | 0.43% | – | |
| CNST | Buy | CONSTELLATION PHARMCETICLS I | $15,496,000 | +111.1% | 515,680 | +120.8% | 0.42% | +40.3% |
| GH | GUARDANT HEALTH INC | $15,415,000 | +16.6% | 190,000 | 0.0% | 0.42% | -22.7% | |
| FOLD | Buy | AMICUS THERAPEUTICS INC | $15,334,000 | +66.0% | 1,016,821 | +1.7% | 0.42% | +10.2% |
| CVET | Buy | COVETRUS INC | $14,983,000 | +8818.5% | 837,500 | +3949.2% | 0.41% | +5771.4% |
| BHVN | Buy | BIOHAVEN PHARMACTL HLDG CO L | $14,901,000 | +118.9% | 203,817 | +1.9% | 0.41% | +45.6% |
| JNJ | JOHNSON & JOHNSON | $14,766,000 | +7.2% | 105,000 | 0.0% | 0.40% | -28.8% | |
| GWPH | Buy | GW PHARMACEUTICALS PLCads | $14,732,000 | +460.8% | 120,043 | +300.1% | 0.40% | +270.6% |
| DVAX | Buy | DYNAVAX TECHNOLOGIES CORP | $14,725,000 | +164.8% | 1,660,120 | +5.4% | 0.40% | +75.7% |
| AGLE | Buy | AEGLEA BIOTHERAPEUTICS INC | $14,712,000 | +294.6% | 1,590,528 | +98.8% | 0.40% | +162.3% |
| RDUS | Buy | RADIUS HEALTH INC | $13,674,000 | +7.9% | 1,003,259 | +2.9% | 0.38% | -28.4% |
| MNTA | MOMENTA PHARMACEUTICALS INC | $13,308,000 | +22.3% | 400,000 | 0.0% | 0.36% | -18.9% | |
| TGTX | New | TG THERAPEUTICS INC | $13,303,000 | – | 682,926 | +100.0% | 0.36% | – |
| PPD | Buy | PPD INC | $13,065,000 | +63.0% | 487,500 | +8.3% | 0.36% | +8.2% |
| CNMD | CONMED CORP | $12,958,000 | +25.7% | 180,000 | 0.0% | 0.36% | -16.7% | |
| FGEN | Buy | FIBROGEN INC | $12,785,000 | +20.2% | 315,449 | +3.1% | 0.35% | -20.2% |
| DCPH | Sell | DECIPHERA PHARMACEUTICALS IN | $12,531,000 | -9.1% | 209,829 | -37.4% | 0.34% | -39.6% |
| HCAT | HEALTH CATALYST INC | $12,397,000 | +11.5% | 425,000 | 0.0% | 0.34% | -26.1% | |
| TBIO | Sell | TRANSLATE BIO INC | $11,850,000 | +44.1% | 661,268 | -19.8% | 0.32% | -4.4% |
| BFAM | New | BRIGHT HORIZONS FAM SOL IN D | $11,544,000 | – | 98,500 | +100.0% | 0.32% | – |
| RYTM | Buy | RHYTHM PHARMACEUTICALS INC | $11,420,000 | +50.1% | 512,111 | +2.4% | 0.31% | -0.6% |
| ZGNX | Buy | ZOGENIX INC | $11,236,000 | +13.6% | 415,982 | +4.0% | 0.31% | -24.7% |
| IMVT | Buy | IMMUNOVANT INC | $11,014,000 | +183.1% | 452,319 | +80.9% | 0.30% | +87.6% |
| RIGL | Buy | RIGEL PHARMACEUTICALS INC | $10,793,000 | +25.8% | 5,897,642 | +7.2% | 0.30% | -16.6% |
| MYOV | Buy | MYOVANT SCIENCES LTD | $10,483,000 | +177.7% | 508,411 | +1.7% | 0.29% | +84.6% |
| NVCR | NOVOCURE LTD | $10,378,000 | -11.9% | 175,000 | 0.0% | 0.28% | -41.5% | |
| PRTA | Buy | PROTHENA CORP PLC | $10,347,000 | +93.4% | 989,218 | +97.8% | 0.28% | +28.5% |
| IMRA | Sell | IMARA INC | $10,078,000 | +41.0% | 364,733 | -18.2% | 0.28% | -6.8% |
| SWAV | New | SHOCKWAVE MED INC | $9,356,000 | – | 197,500 | +100.0% | 0.26% | – |
| GMDA | Buy | GAMIDA CELL LTD | $9,216,000 | +205.2% | 2,016,656 | +101.7% | 0.25% | +102.4% |
| LEGN | New | LEGEND BIOTECH CORPsponsored ads | $8,763,000 | – | 205,896 | +100.0% | 0.24% | – |
| PRTK | Buy | PARATEK PHARMACEUTICALS INC | $8,640,000 | +79.7% | 1,655,164 | +8.4% | 0.24% | +19.1% |
| RPTX | New | REPARE THERAPEUTICS INC | $8,525,000 | – | 274,815 | +100.0% | 0.23% | – |
| OBSV | Buy | OBSEVA SA | $8,385,000 | +148.5% | 1,423,552 | +1.7% | 0.23% | +64.3% |
| SPRO | Buy | SPERO THERAPEUTICS INC | $8,323,000 | +70.3% | 615,177 | +1.7% | 0.23% | +12.9% |
| OSW | Buy | ONESPAWORLD HOLDINGS LIMITED | $8,300,000 | +94.7% | 1,740,000 | +65.7% | 0.23% | +29.5% |
| STAA | Sell | STAAR SURGICAL CO | $8,000,000 | +60.0% | 130,000 | -16.1% | 0.22% | +5.8% |
| CHMA | Buy | CHIASMA INC | $7,491,000 | +52.0% | 1,392,312 | +3.1% | 0.20% | +0.5% |
| BLU | New | BELLUS HEALTH INC NEW | $7,163,000 | – | 696,115 | +100.0% | 0.20% | – |
| NGM | Buy | NGM BIOPHARMACEUTICALS INC | $7,055,000 | +63.0% | 357,409 | +1.8% | 0.19% | +8.4% |
| IGMS | New | IGM BIOSCIENCES INC | $6,955,000 | – | 95,278 | +100.0% | 0.19% | – |
| ANAB | Buy | ANAPTYSBIO INC | $6,852,000 | +61.6% | 306,713 | +2.2% | 0.19% | +7.4% |
| XENT | INTERSECT ENT INC | $6,770,000 | +14.3% | 500,000 | 0.0% | 0.19% | -24.1% | |
| TXG | 10X GENOMICS INC | $6,788,000 | +43.3% | 76,000 | 0.0% | 0.19% | -5.1% | |
| MGNX | Buy | MACROGENICS INC | $6,548,000 | +389.0% | 234,516 | +2.0% | 0.18% | +227.3% |
| XENE | Buy | XENON PHARMACEUTICALS INC | $6,467,000 | +14.1% | 515,711 | +3.1% | 0.18% | -24.4% |
| Buy | TRILLIUM THERAPEUTICS INC | $6,170,000 | +103.6% | 762,618 | +1.7% | 0.17% | +35.2% | |
| AKRO | Buy | AKERO THERAPEUTICS INC | $6,055,000 | +26.9% | 242,985 | +8.0% | 0.17% | -15.7% |
| INSMED INCnote 1.750% 1/1 | $5,861,000 | +16.3% | 6,000,000 | 0.0% | 0.16% | -22.6% | ||
| PASG | Sell | PASSAGE BIO INC | $5,560,000 | +56.9% | 203,436 | -9.6% | 0.15% | +4.1% |
| BNR | New | BURNING ROCK BIOTECH LTDsponsored ads | $5,402,000 | – | 200,000 | +100.0% | 0.15% | – |
| FIXX | Sell | HOMOLOGY MEDICINES INC | $5,341,000 | -19.1% | 351,638 | -17.3% | 0.15% | -46.5% |
| PHAS | Buy | PHASEBIO PHARMACEUTICALS INC | $5,262,000 | +41.3% | 1,143,925 | +1.7% | 0.14% | -6.5% |
| GRTX | Buy | GALERA THERAPEUTICS INC | $4,052,000 | -14.7% | 567,552 | +13.5% | 0.11% | -43.4% |
| NARI | New | INARI MED INC | $3,875,000 | – | 80,000 | +100.0% | 0.11% | – |
| CO | GLOBAL CORD BLOOD CORPORATIO | $2,868,000 | -2.5% | 925,000 | 0.0% | 0.08% | -35.2% | |
| RETROPHIN INCnote 2.500% 9/1 | $2,713,000 | +5.7% | 3,250,000 | 0.0% | 0.07% | -30.2% | ||
| ACRS | Buy | ACLARIS THERAPEUTICS INC | $2,663,000 | +60.0% | 1,644,015 | +2.8% | 0.07% | +5.8% |
| FPRX | Buy | FIVE PRIME THERAPEUTICS INC | $2,481,000 | +173.2% | 406,729 | +1.7% | 0.07% | +78.9% |
| CYTK | New | CYTOKINETICS INC | $1,825,000 | – | 77,417 | +100.0% | 0.05% | – |
| NEUROCRINE BIOSCIENCES INCnote 2.250% 5/1 | $1,673,000 | +30.0% | 1,000,000 | 0.0% | 0.05% | -13.2% | ||
| THERAVANCE BIOPHARMA INCnote 3.250%11/0 | $1,460,000 | +0.8% | 1,500,000 | 0.0% | 0.04% | -33.3% | ||
| RADIUS HEALTH INCnote 3.000% 9/0 | $1,105,000 | +3.6% | 1,500,000 | 0.0% | 0.03% | -31.8% | ||
| PACIRA BIOSCIENCESnote 2.375% 4/0 | $1,094,000 | +13.3% | 1,000,000 | 0.0% | 0.03% | -25.0% | ||
| Buy | NABRIVA THERAPEUTICS PLC | $720,000 | +19.2% | 1,067,664 | +1.7% | 0.02% | -20.0% | |
| New | NEVRO CORPnote 2.750% 4/0 | $683,000 | – | 500,000 | +100.0% | 0.02% | – | |
| BMYRT | BRISTOL-MYERS SQUIBB COright 99/99/9999 | $663,000 | -5.8% | 185,150 | 0.0% | 0.02% | -37.9% | |
| XLRN | Exit | ACCELERON PHARMA INC | $0 | – | -17,500 | -100.0% | -0.06% | – |
| AXNX | Exit | AXONICS MODULATION TECHNOLOG | $0 | – | -125,000 | -100.0% | -0.13% | – |
| TMO | Exit | THERMO FISHER SCIENTIFIC INC | $0 | – | -17,500 | -100.0% | -0.20% | – |
| FTSV | Exit | FORTY SEVEN INC | $0 | – | -447,400 | -100.0% | -1.76% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| INTUITIVE SURGICAL INC | 40 | Q3 2023 | 3.4% |
| NEUROCRINE BIOSCIENCES INC | 39 | Q3 2023 | 4.8% |
| PACIRA PHARMACEUTICALS INC | 39 | Q3 2023 | 2.6% |
| ULTRAGENYX PHARMACEUTICAL IN | 39 | Q3 2023 | 1.9% |
| ACADIA HEALTHCARE COMPANY IN | 38 | Q3 2023 | 4.4% |
| ASCENDIS PHARMA A/S | 35 | Q3 2023 | 1.3% |
| INVITAE CORP | 35 | Q3 2023 | 1.8% |
| BIOMARIN PHARMACEUTICAL INC | 35 | Q3 2023 | 1.3% |
| MACROGENICS INC | 35 | Q3 2023 | 0.5% |
| COLLEGIUM PHARMACEUTICAL INC | 34 | Q3 2023 | 2.1% |
View Rock Springs Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aeglea BioTherapeutics, Inc. | February 14, 2023 | 3,413,906 | 5.6% |
| Compass Therapeutics, Inc. | February 14, 2023 | 5,333,188 | 4.2% |
| Mirum Pharmaceuticals, Inc. | February 14, 2023 | 1,795,733 | 4.9% |
| PhaseBio Pharmaceuticals IncSold out | February 14, 2023 | 0 | 0.0% |
| Sierra Oncology, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| ARDELYX, INC.Sold out | February 15, 2022 | 0 | 0.0% |
| CHIASMA, INCSold out | February 15, 2022 | 0 | 0.0% |
| FIVE PRIME THERAPEUTICS, INC.Sold out | February 15, 2022 | 0 | 0.0% |
| F-star Therapeutics, Inc. | February 15, 2022 | 751,889 | 3.6% |
| Protara Therapeutics, Inc.Sold out | February 15, 2022 | 0 | 0.0% |
View Rock Springs Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-04-05 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Rock Springs Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.